Global Biosimilar Drug Market Report and Forecast to 2021


Report ID : RNR-191038 Category : Medical Devices Published Date : 7-Sep-2017
Publisher : 9Dimen Pages : 165 Format : PDF
Biosimilar Drug Report by Material, Application, and Geography ? Global Forecast to 2021 is a professional and comprehensive research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, United Kingdom,Japan, South Korea and China).

In this report, the global Biosimilar Drug market is valued at USD XX million in 2017 and is projected to reach USD XX million by the end of 2021, growing at a CAGR of XX% during the period 2017 to 2021.

The report firstly introduced the Biosimilar Drug basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main region market conditions, including the product price, profit, capacity, production, supply, demand and market growth rate and forecast etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.

The major players profiled in this report include:
Hengrui Medicine
Hisun Pharm
MSD
Pfizer
Novartis
Boehringer
??

The end users/applications and product categories analysis:
On the basis of product, this report displays the sales volume, revenue (Million USD), product price, market share and growth rate of each type, primarily split into-
mAbs (Monoclonal Antibodies)
FC-Fusion Proteins
EPO (Erythropoietin)
??

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biosimilar Drug for each application, including-
Oncology
Diabetes
Rheumatoid arthritis
Table of Contents 

Part I Biosimilar Drug Industry Overview 

Chapter One Biosimilar Drug Industry Overview 
1.1 Biosimilar Drug Definition 
1.2 Biosimilar Drug Classification Analysis 
mAbs (Monoclonal Antibodies) 
FC-Fusion Proteins 
EPO (Erythropoietin) 
?? 
1.2.1 Biosimilar Drug Main Classification Analysis 
1.2.2 Biosimilar Drug Main Classification Share Analysis 
1.3 Biosimilar Drug Application Analysis 
Oncology 
Diabetes 
Rheumatoid arthritis 
?? 
1.3.1 Biosimilar Drug Main Application Analysis 
1.3.2 Biosimilar Drug Main Application Share Analysis 
1.4 Biosimilar Drug Industry Chain Structure Analysis 
1.5 Biosimilar Drug Industry Development Overview 
1.5.1 Biosimilar Drug Product History Development Overview 
1.5.1 Biosimilar Drug Product Market Development Overview 
1.6 Biosimilar Drug Global Market Comparison Analysis 
1.6.1 Biosimilar Drug Global Import Market Analysis 
1.6.2 Biosimilar Drug Global Export Market Analysis 
1.6.3 Biosimilar Drug Global Main Region Market Analysis 
1.6.4 Biosimilar Drug Global Market Comparison Analysis 
1.6.5 Biosimilar Drug Global Market Development Trend Analysis 

Chapter Two Biosimilar Drug Up and Down Stream Industry Analysis 
2.1 Upstream Raw Materials Analysis 
2.1.1 Upstream Raw Materials Price Analysis 
2.1.2 Upstream Raw Materials Market Analysis 
2.1.3 Upstream Raw Materials Market Trend 
2.2 Down Stream Market Analysis 
2.1.1 Down Stream Market Analysis 
2.2.2 Down Stream Demand Analysis 
2.2.3 Down Stream Market Trend Analysis 

Part II Asia Biosimilar Drug Industry (The Report Company Including the Below Listed But Not All) 
  
Chapter Three Asia Biosimilar Drug Market Analysis 
3.1 Asia Biosimilar Drug Product Development History 
3.2 Asia Biosimilar Drug Competitive Landscape Analysis 
3.3 Asia Biosimilar Drug Market Development Trend 

Chapter Four 2012-2017 Asia Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast 
4.1 2012-2017 Biosimilar Drug Capacity Production Overview 
4.2 2012-2017 Biosimilar Drug Production Market Share Analysis 
4.3 2012-2017 Biosimilar Drug Demand Overview 
4.4 2012-2017 Biosimilar Drug Supply Demand and Shortage Analysis 
4.5 2012-2017 Biosimilar Drug Import Export Consumption Analysis 
4.6 2012-2017 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Five Asia Biosimilar Drug Key Manufacturers Analysis 
5.1 Hengrui Medicine 
5.1.1 Company Profile 
5.1.2 Product Picture and Specification 
5.1.3 Product Application Analysis 
5.1.4 Capacity Production Price Cost Production Value Analysis 
5.1.5 Contact Information 
5.2 Hisun Pharm 
5.2.1 Company Profile 
5.2.2 Product Picture and Specification 
5.2.3 Product Application Analysis 
5.2.4 Capacity Production Price Cost Production Value Analysis 
5.2.5 Contact Information 
5.3 Company C 
5.3.1 Company Profile 
5.3.2 Product Picture and Specification 
5.3.3 Product Application Analysis 
5.3.4 Capacity Production Price Cost Production Value Analysis 
5.3.5 Contact Information 
... 
... 
Chapter Six Asia Biosimilar Drug Industry Development Trend 
6.1 2017-2021 Biosimilar Drug Capacity Production Trend 
6.2 2017-2021 Biosimilar Drug Production Market Share Analysis 
6.3 2017-2021 Biosimilar Drug Demand Trend 
6.4 2017-2021 Biosimilar Drug Supply Demand and Shortage Analysis 
6.5 2017-2021 Biosimilar Drug Import Export Consumption Analysis 
6.6 2017-2021 Biosimilar Drug Cost Price Production Value Profit Analysis 

Part III North American Biosimilar Drug Industry (The Report Company Including the Below Listed But Not All) 
  
Chapter Seven North American Biosimilar Drug Market Analysis 
7.1 North American Biosimilar Drug Product Development History 
7.2 North American Biosimilar Drug Competitive Landscape Analysis 
7.3 North American Biosimilar Drug Market Development Trend 

Chapter Eight 2012-2017 North American Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast 
8.1 2012-2017 Biosimilar Drug Capacity Production Overview 
8.2 2012-2017 Biosimilar Drug Production Market Share Analysis 
8.3 2012-2017 Biosimilar Drug Demand Overview 
8.4 2012-2017 Biosimilar Drug Supply Demand and Shortage Analysis 
8.5 2012-2017 Biosimilar Drug Import Export Consumption Analysis 
8.6 2012-2017 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Nine North American Biosimilar Drug Key Manufacturers Analysis 
9.1 MSD 
9.1.1 Company Profile 
9.1.2 Product Picture and Specification 
9.1.3 Product Application Analysis 
9.1.4 Capacity Production Price Cost Production Value Analysis 
9.1.5 Contact Information 
9.1 Pfizer 
9.2.1 Company Profile 
9.2.2 Product Picture and Specification 
9.2.3 Product Application Analysis 
9.2.4 Capacity Production Price Cost Production Value Analysis 
9.2.5 Contact Information 
... 
... 
Chapter Ten North American Biosimilar Drug Industry Development Trend 
10.1 2017-2021 Biosimilar Drug Capacity Production Trend 
10.2 2017-2021 Biosimilar Drug Production Market Share Analysis 
10.3 2017-2021 Biosimilar Drug Demand Trend 
10.4 2017-2021 Biosimilar Drug Supply Demand and Shortage Analysis 
10.5 2017-2021 Biosimilar Drug Import Export Consumption Analysis 
10.6 2017-2021 Biosimilar Drug Cost Price Production Value Profit Analysis 

Part IV Europe Biosimilar Drug Industry Analysis (The Report Company Including the Below Listed But Not All) 

Chapter Eleven Europe Biosimilar Drug Market Analysis 
11.1 Europe Biosimilar Drug Product Development History 
11.2 Europe Biosimilar Drug Competitive Landscape Analysis 
11.3 Europe Biosimilar Drug Market Development Trend 

Chapter Twelve 2012-2017 Europe Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast 
12.1 2012-2017 Biosimilar Drug Capacity Production Overview 
12.2 2012-2017 Biosimilar Drug Production Market Share Analysis 
12.3 2012-2017 Biosimilar Drug Demand Overview 
12.4 2012-2017 Biosimilar Drug Supply Demand and Shortage Analysis 
12.5 2012-2017 Biosimilar Drug Import Export Consumption Analysis 
12.6 2012-2017 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Thirteen Europe Biosimilar Drug Key Manufacturers Analysis 
13.1 Novartis 
13.1.1 Company Profile 
13.1.2 Product Picture and Specification 
13.1.3 Product Application Analysis 
13.1.4 Capacity Production Price Cost Production Value Analysis 
13.1.5 Contact Information 
13.2 Boehringer 
13.2.1 Company Profile 
13.2.2 Product Picture and Specification 
13.2.3 Product Application Analysis 
13.2.4 Capacity Production Price Cost Production Value Analysis 
13.2.5 Contact Information 
... 
... 
Chapter Fourteen Europe Biosimilar Drug Industry Development Trend 
14.1 2017-2021 Biosimilar Drug Capacity Production Trend 
14.2 2017-2021 Biosimilar Drug Production Market Share Analysis 
14.3 2017-2021 Biosimilar Drug Demand Trend 
14.4 2017-2021 Biosimilar Drug Supply Demand and Shortage Analysis 
14.5 2017-2021 Biosimilar Drug Import Export Consumption Analysis 
14.6 2017-2021 Biosimilar Drug Cost Price Production Value Profit Analysis 

Part V Biosimilar Drug Marketing Channels and Investment Feasibility 

Chapter Fifteen Biosimilar Drug Marketing Channels Development Proposals Analysis 
15.1 Biosimilar Drug Marketing Channels Status 
15.2 Biosimilar Drug Marketing Channels Characteristic 
15.3 Biosimilar Drug Marketing Channels Development Trend 
15.2 New Firms Enter Market Strategy 
15.3 New Project Investment Proposals 

Chapter Sixteen Development Environmental Analysis 
16.1 China Macroeconomic Environment Analysis 
16.2 European Economic Environmental Analysis 
16.3 United States Economic Environmental Analysis 
16.4 Japan Economic Environmental Analysis 
16.5 Global Economic Environmental Analysis 

Chapter Seventeen Biosimilar Drug New Project Investment Feasibility Analysis 
17.1 Biosimilar Drug Market Analysis 
17.2 Biosimilar Drug Project SWOT Analysis 
17.3 Biosimilar Drug New Project Investment Feasibility Analysis 

Part VI Global Biosimilar Drug Industry Conclusions 

Chapter Eighteen 2012-2017 Global Biosimilar Drug Productions Supply Sales Demand Market Status and Forecast 
18.1 2012-2017 Biosimilar Drug Capacity Production Overview 
18.2 2012-2017 Biosimilar Drug Production Market Share Analysis 
18.3 2012-2017 Biosimilar Drug Demand Overview 
18.4 2012-2017 Biosimilar Drug Supply Demand and Shortage Analysis 
18.5 2012-2017 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Nineteen Global Biosimilar Drug Industry Development Trend 
19.1 2017-2021 Biosimilar Drug Capacity Production Trend 
19.2 2017-2021 Biosimilar Drug Production Market Share Analysis 
19.3 2017-2021 Biosimilar Drug Demand Trend 
19.4 2017-2021 Biosimilar Drug Supply Demand and Shortage Analysis 
19.5 2017-2021 Biosimilar Drug Cost Price Production Value Profit Analysis 

Chapter Twenty Global Biosimilar Drug Industry Research Conclusions